Rapid point-of-care (POC) testing for Hepatitis C antibodies in a very high prevalence setting: persons injecting drugs in Tallinn, Estonia
Abstract Background Between December 2018 and January of 2019, we evaluated the accuracy of the point-of-care Hepatitis C (HCV) antibody test (POC; OraQuick HCV) used at a community-based needle and syringe exchange program serving persons who inject drugs in Tallinn, Estonia. Methods We compared th...
Main Authors: | Anneli Uusküla, Ave Talu, Jürgen Rannap, David M. Barnes, Don Des Jarlais |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-04-01
|
Series: | Harm Reduction Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12954-021-00485-5 |
Similar Items
-
Non-disclosure of drug injection practices as a barrier to HCV testing: results from the PrebupIV community-based research study
by: Ilhame Anwar, et al.
Published: (2023-07-01) -
Hepatitis C Virus Dynamic Transmission Models Among People Who Inject Drugs
by: Woyesa SB, et al.
Published: (2023-02-01) -
Usability and acceptability of oral fluid hepatitis C self-testing among people who inject drugs in Coastal Kenya: a cross-sectional pilot study
by: Elena Ivanova Reipold, et al.
Published: (2022-09-01) -
Directly Acting Antiviral-Based Treatment for HCV-Infected Persons Who Inject Drugs: A Multicenter Real-Life Study
by: Vincenzo Messina, et al.
Published: (2020-12-01) -
Injection Drug use and Hepatitis C: Interventions in Behavioral Health Settings
by: Marie Sutton
Published: (2017-07-01)